Authors
Mohamed Saad Sayed, Doaa Mohamed Gebaly, Hasan Ilyas, Rawan Abdelhamed, Waleed Mohaned Rasheed, Hossam Hamdy, Lydia Melad, Giuseppe Andò, Toshiki Kuno, Islam Y Elgendy
Published in
Lung. Volume 204. Issue 1. Nov 10, 2026. Epub Nov 10, 2026.
Abstract
Randomized trials comparing the outcomes with catheter-directed medical thrombolysis (CDT) versus mechanical thrombectomy (MT) for patients with intermediate/high risk pulmonary embolism (PE) are limited. This meta-analysis aimed to assess the clinical outcomes after CDT versus MT for patients with intermediate/high risk PE.
Eligible studies compared CDT and MT for patients with intermediate/high risk PE underwent catheter-based therapies were retrieved from a comprehensive literature search for PubMed, Web of Science, Scopus, and Cochrane CENTRAL through June 2026. Outcomes included all-cause mortality, major bleeding, and the length of intensive care unit (ICU) stay. Summary estimates were analyzed using a random effects model.
A total of 18 studies (24,090 intermediate/high risk patients) were eligible for the analysis. CDT was associated with longer length of intensive care unit (ICU) stay (mean difference: 1.01 days, 95% confidence interval [CI] 0.87-1.15) compared with MT. While there was no statistical difference between the two groups regarding the risk of all-cause mortality (risk ratio [RR] 0.88, 95% CI 0.76-1.01, p = 0.068) and major bleeding (RR 1.07, 95% CI 0.74-1.55, p = 0.705). Similarly, the incidence of other clinical outcomes; all-cause readmission, PE-related readmission, blood transfusion rates, length of hospital stay, cardiac arrest, and stroke, were similar between the two groups.
Among patients with intermediate/high risk PE treated with catheter-based therapies, there was no difference regarding the clinical outcomes between CDT and MT, but CDT was associated with a longer ICU stay. Larger, well designed randomized trials are needed to confirm these findings.
PMID:
43007443
Bibliographic data and abstract were imported from PubMed on 11 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 10
- Comments 0